KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silicon Laboratories (SLAB) Shares Outstanding (Diluted Average) (2018 - 2026)

Silicon Laboratories (SLAB) has 12 years of Shares Outstanding (Diluted Average) data on record, last reported at $32.7 million in Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) rose 1.65% year-over-year to $32.7 million; the TTM value through Jan 2026 reached $32.7 million, up 1.65%, while the annual FY2026 figure was $32.7 million, 1.65% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $32.7 million in Q1 2026 per SLAB's latest filing, roughly flat from $32.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $44.3 million in Q1 2022 and bottomed at $31.8 million in Q4 2023.
  • Average Shares Outstanding (Diluted Average) over 5 years is $34.4 million, with a median of $32.8 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): decreased 20.0% in 2022, then rose 1.74% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $36.0 million in 2022, then decreased by 11.76% to $31.8 million in 2023, then increased by 1.22% to $32.2 million in 2024, then grew by 2.0% to $32.8 million in 2025, then dropped by 0.35% to $32.7 million in 2026.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $32.7 million in Q1 2026, $32.8 million in Q4 2025, and $32.7 million in Q3 2025.